Pharm­ing ends deal with Or­chard; Seres con­sid­ers cost-cut­ting

Plus, news about Think Bio­science and Apel­lis:

Pharm­ing ax­es Or­chard pact: The Dutch bio­phar­ma ter­mi­nat­ed a re­search col­lab­o­ra­tion and li­cens­ing agree­ment with Or­chard Ther­a­peu­tics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER